Wei‐Chiao Chang
Impact in
- Sensory Systems top 1%
- Ion Channels and Receptors
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Ion Channels and Receptors 21
- Co-authors
- Ho‐Chang KuoKuender D. YangMing‐Feng HouWei-Pin ChangAnant B. ParekhCharmaine NelsonYu-Wen HsuHenry Sung-Ching Wong
- Journals
- PLoS ONE (21 papers)Journal of Biomedical Science (9 papers)Journal of Biological Chemistry (6 papers)Journal of Personalized Medicine (6 papers)Scientific Reports (5 papers)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Wei‐Chiao Chang
255 papers receiving 5.2k citations
Peers
Comparison fields: 5 of 163
- Sensory Systems 434
- Cancer Research 596
- Immunology 642
- Biological Psychiatry 76
- Pulmonary and Respiratory Medicine 982
Countries citing papers authored by Wei‐Chiao Chang
This map shows the geographic impact of Wei‐Chiao Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Chiao Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Chiao Chang more than expected).
Fields of papers citing papers by Wei‐Chiao Chang
This network shows the impact of papers produced by Wei‐Chiao Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Chiao Chang. The network helps show where Wei‐Chiao Chang may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei‐Chiao Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 6 | |
| 4 | 2023 | 7 | |
| 5 | 2023 | 16 | |
| 6 | 2022 | 20 | |
| 7 | 2021 | 8 | |
| 8 | 2021 | 29 | |
| 9 | 2020 | 5 | |
| 10 | 2020 | 9 | |
| 11 | 2020 | 15 | |
| 12 | 2020 | 24 | |
| 13 | 2018 | 24 | |
| 14 | 2017 | 1 | |
| 15 | 2016 | 30 | |
| 16 | 2011 | 52 | |
| 17 | Understanding time to treatment in acute myocardial infarction: insights from ASSENT 3 plus | 2003 | 1 |
| 18 | What is an Optimal Rate of Early Revascularization After ST-elevation Myocardial Infarction? Insights from the GUSTO-V Trial | 2003 | 2 |
| 19 | The ST-Depression >=2 mm sign: an ominous prognosis in acute coronary syndromes | 1999 | 1 |
| 20 | Acute Coronary Syndromes: Prognostic Insights from GUSTO IIb | 1998 | 3 |
About Wei‐Chiao Chang
Wei‐Chiao Chang is a scholar working on Sensory Systems, Toxicology, Nephrology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 266 papers that have together received 5.2k indexed citations. Recurring topics across this work include Kawasaki Disease and Coronary Complications (33 papers), Coronary Artery Anomalies (30 papers), Ion Channels and Receptors (21 papers), Inflammatory mediators and NSAID effects (16 papers), Ion channel regulation and function (8 papers), Dermatology and Skin Diseases (8 papers), Cardiovascular Issues in Pregnancy (8 papers) and Cancer Immunotherapy and Biomarkers (7 papers). The work is most often cited by research in Sensory Systems (434 citations), Cancer Research (596 citations), Immunology (642 citations), Biological Psychiatry (76 citations) and Pulmonary and Respiratory Medicine (982 citations). Wei‐Chiao Chang has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Ho‐Chang Kuo, Kuender D. Yang, Ming‐Feng Hou, Wei-Pin Chang, Anant B. Parekh, Charmaine Nelson, Yu-Wen Hsu, Henry Sung-Ching Wong, Ku‐Chung Chen and Yu‐Shiuan Wang. Their work appears in journals such as PLoS ONE, Journal of Biomedical Science, Journal of Biological Chemistry, Journal of Personalized Medicine and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.